Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Oriza Holdings

Investor type Venture Capital


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Looking for a perfect list of funds?

Get recommendations from our smart algorithm

Get the list
Total investments 125
Average round size
The average size of a deal this fund participated in
Portfolio companies 100
Rounds per year 5.68
Lead investments 15
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 7
Key employees Soon
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Health Care
  • Manufacturing
  • Biotechnology
  • Software
  • Artificial Intelligence

Oriza Holdings is the famous VC, which was founded in 2007. The leading representative office of defined VC is situated in the Suzhou. The venture was found in Asia in China.

The important activity for fund was in 2019. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in 2-6 deals per year. Comparing to the other companies, this Oriza Holdings performs on 21 percentage points less the average number of lead investments. The increased amount of exits for fund were in 2018. The average startup value when the investment from Oriza Holdings is 100-500 millions dollars. Speaking about the real fund results, this VC is 16 percentage points more often commits exit comparing to other organizations.

The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Oriza Holdings, startups are often financed by Correlation Ventures, ff Venture Capital, Eastern Bell Venture Capital. The meaningful sponsors for the fund in investment in the same round are Correlation Ventures, ff Venture Capital, Tencent Holdings. In the next rounds fund is usually obtained by Tencent Holdings, ff Venture Capital, Legend Capital.

Among the most successful fund investment fields, there are Internet, Information Technology. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. The fund has exact preference in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Among the most popular portfolio startups of the fund, we may highlight Cloudwalk,, UCloud Information Technology.

Read more

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Cui Zhan Microelectronics

Application Specific Integrated Circuit (ASIC)
$15M16 Jan 2023 Shanghai, Shanghai, China

Qianjing Semiconductor

Electrical Distribution
$15M13 Jan 2023 Hangzhou, Zhejiang, China

MDS Semiconductor

Power Grid
$13M30 Dec 2022 Suzhou, Jiangsu, China

Huiwei Intelligent Medical

Artificial Intelligence
Health Care
26 Dec 2022 Suzhou, Jiangsu, China


Electric Vehicle
Supply Chain Management
15 Sep 2022 Suzhou, Jiangsu, China


07 Sep 2022 Suzhou, Jiangsu, China


Application Specific Integrated Circuit (ASIC)
Artificial Intelligence
Internet of Things
09 Aug 2022 Hefei, Anhui, China


28 Jul 2022 Shanghai, China

Ark Biosciences

Health Care
14 Jul 2022 Shanghai, China
Tavotek Biotherapeutics Snares $20M in Series A

– Tavotek Biotherapeutics from Lower Gwynedd, Pennsylvania, has raised over $20M in financing in the preceding two months.
YuanBio Venture Capital led the A1 finance round followed by Oriza Holdings, Ming BioVentures, and New Alliance Capital.
– Series A2 financing was jointly invested by GF Xinde, CTS Capital, and Lanhu Capital.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Oriza Holdings?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: